<DOC>
	<DOCNO>NCT02731313</DOCNO>
	<brief_summary>The primary objective evaluate concordance human epidermal growth factor receptor 2 ( HER2 ) status determine participate laboratory centralized laboratory . HER2 status sample test participate laboratory ( investigator 's choice immunohistochemistry [ IHC ] situ hybridization [ ISH ] method ) centralize laboratory ( IHC use 4B5 anti-HER antibody Silver ISH ) . Positive HER2 status define score IHC3+ IHC2+/ISH+ .</brief_summary>
	<brief_title>Human Epidermal Growth Factor Receptor 2 ( HER-2 ) Status Gastric Gastro-Esophageal Junction ( GEJ ) Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Tumor sample histologically confirm gastric gastroesophageal junction ( GEJ ) adenocarcinoma , stage Samples sufficient tumor material centralize analysis Samples fixed embed paraffin ( formalinfixed paraffinembedded tissue [ FFPET ] sample ) . Fixatives allow : Bouin 's solution</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>